Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.33
-1.1%
$103.93
$81.97
▼
$132.02
$185.89B0.5411.10 million shs8.62 million shs
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$585.21
-1.8%
$553.61
$437.25
▼
$692.00
$135.19B0.071.46 million shs1.11 million shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-1.30%+3.63%-1.88%-16.84%
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
0.00%+5.20%+7.96%+0.27%+27.80%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.33
-1.1%
$103.93
$81.97
▼
$132.02
$185.89B0.5411.10 million shs8.62 million shs
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$585.21
-1.8%
$553.61
$437.25
▼
$692.00
$135.19B0.071.46 million shs1.11 million shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-1.30%+3.63%-1.88%-16.84%
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
0.00%+5.20%+7.96%+0.27%+27.80%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.89
Moderate Buy$118.3210.24% Upside
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
2.52
Moderate Buy$647.0010.56% Upside

Current Analyst Ratings Breakdown

Latest ABT and LMT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/4/2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Initiated CoverageBuy$735.00
11/2/2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Boost Price TargetEqual Weight$600.00 ➝ $700.00
10/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeBuy ➝ Hold
10/26/2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Reiterated RatingNeutral$620.00
10/26/2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Boost Price TargetNeutral$620.00 ➝ $665.00
10/25/2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Reiterated RatingHold$615.00
10/23/2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Boost Price TargetBuy$653.00 ➝ $692.00
10/23/2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Boost Price TargetSector Perform$550.00 ➝ $600.00
10/23/2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Boost Price TargetBuy$691.00 ➝ $706.00
10/23/2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Boost Price TargetEqual Weight$554.00 ➝ $560.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$125.00 ➝ $122.00
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$48.23B3.85$6.92 per share15.52$30.35 per share3.54
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$75.05B1.80$35.62 per share16.43$29.21 per share20.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$2.6840.0518.131.909.75%18.04%9.09%1/28/2027 (Estimated)
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$5.02B$28.1520.7917.391.268.23%83.41%11.20%1/26/2027 (Estimated)

Latest ABT and LMT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/22/2026Q3 2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$7.52$7.97+$0.45$7.97$20.48 billion$20.71 billion
10/21/2026Q3 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.42$1.42N/A$0.53$12.99 billion$13.01 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.35%+10.39%94.03%54 Years
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$13.802.36%+6.38%49.02%24 Years

Latest ABT and LMT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/9/2026
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
quarterly$3.602.82%12/1/202612/1/202612/31/2026
9/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.4%10/15/202610/15/202611/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.57
1.45
1.00
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
2.04
1.26
1.10

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
74.19%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
0.13%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.72 billionOptionable
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
123,000231.01 million230.71 millionOptionable

Recent News About These Companies

Illuminated AV logo glowing on a dark circuit board background, representing a technology company.
Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal (LMT)
...
Lockheed Martin (NYSE:LMT) Shares Down 1.4% - Time to Sell?
Firefly Aerospace logo beside a rocket on a launch tower at sunset, with a hangar facility in the background.
Firefly Aerospace Lights Up a High-Risk Space Opportunity (LMT)
...
Conceptual image combining a missile defense system launch with a data center, linked by a golden dome network.
Golden Dome’s $185 Billion Question: Who Actually Gets Paid? (LMT)
...
LMT vs. HWM: Which Stock Is the Better Value Option?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$107.33 -1.19 (-1.10%)
Closing price 03:59 PM Eastern
Extended Trading
$107.50 +0.16 (+0.15%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Lockheed Martin stock logo

Lockheed Martin NYSE:LMT

$585.21 -10.83 (-1.82%)
Closing price 03:59 PM Eastern
Extended Trading
$585.42 +0.21 (+0.04%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Lockheed Martin Corporation, a security and aerospace company, engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services worldwide. The company operates through Aeronautics, Missiles and Fire Control, Rotary and Mission Systems, and Space segments. The Aeronautics segment offers combat and air mobility aircraft, unmanned air vehicles, and related technologies. The Missiles and Fire Control segment provides air and missile defense systems; tactical missiles and air-to-ground precision strike weapon systems; logistics; fire control systems; mission operations support, readiness, engineering support, and integration services; manned and unmanned ground vehicles; and energy management solutions. The Rotary and Mission Systems segment offers military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment offers satellites; space transportation systems; strategic, advanced strike, and defensive systems; and classified systems and services in support of national security systems. This segment also provides network-enabled situational awareness and integrates space and ground global systems to help its customers gather, analyze, and securely distribute critical intelligence data. It serves primarily serves the U.S. government, as well as foreign military sales contracted through the U.S. government. The company was founded in 1912 and is based in Bethesda, Maryland.